Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT01445509||Active, not recruiting||Dasatinib in Combination With Bevacizumab to Treat Advanced Solid Tumors||
||50||All||18 Years to 100 Years (Adult, Senior)||NCT01445509||090019
|October 30, 2008||December 31, 2018||January 31, 2019||October 3, 2011||October 27, 2017||
|Trial of Pemetrexed and Bevacizumab for Recurrent Ovarian Primary Peritoneal Carcinoma||
||38||Female||18 Years and older (Adult, Senior)||NCT00868192||08-0508 / 201102272||May 2008||December 2012||December 2012||March 24, 2009||October 20, 2014||October 20, 2014||